Lutz, Florida (PRWEB) February 05, 2013 World Stem Cells, LLC. contract laboratory and clinic World Stem Cells Clinic a new adult stem cell laboratory being built in Cancun, Mexico to support Stem Cell research, stem cell clinical trials and stem cell treatments. This was accomplished by private funding in conjunction with World Stem Cells, LLC worldstemcells.com a US patient management company, Medicina Biocelular Avanzada , S.E. de C.V. a Mexican patient management company and World Stem Cells Clinic of Cancun, a Stem Cell treatment Clinic http://worldstemcells.com/clinic-team.html well known board certified hematologist and physicians , in Cancun. The laboratory http://worldstemcells.com/stem-cell-laboratory construction is complete and operations were transferred to our new facility. This facility provides Cancun, and patient around the world, a state of the art cGTP laboratory to support their stem cell treatments in a beautiful, and positive environment. The lab was designed and constructed to provide one ISO7 lab, one wet lab along with a treatment area. This will allow stem cell retrieval, testing, culturing, selection, counting, analyses and sorting along with cryopreservation, without removal from the lab. This all in house capability reduces the possibility of contamination and errors. Dr. M. Abblitt will operate the Lab under cGTP guidelines … Continue reading →

Scientists have taken a step closer to creating artificial human organs and using them for transplants after 3D printing produced clusters of stem cells. In the short term, the technique could be used to generate tissue for drug-testing currently carried out on animals. The 3D printing technology relies on an adjustable "microvalve", which builds up layers of human embryonic stem cells. Such cells, which originate from early stage embryos, are blankslates with the potential to become any type of tissue in the body. In the long term, the new printing technique could pave the way for those cells to be incorporated into transplant-ready laboratory-made organs and tissues, said researchers at Heriot-Watt University in Edinburgh The technique's breakthrough is in its gentle handling of the delicate cells which gives them a greater chance to thrive, they said. Lead scientist Dr Will Shu told Sky News: "We found that the valve-based printing is gentle enough to maintain high stem cell viability". He also said it was "accurate enough to produce spheroids of uniform size and, most importantly, the printed human embryo stem cells maintained their pluripotency - the ability to differentiate into any other cell type". Taking a cell from a patient … Continue reading →

PITTSTON, ME--(Marketwire - Feb 5, 2013) - YaFarm Technologies, Inc. ( PINKSHEETS : YFRM ) (YaFarm, or the Company) is pleased to announce that it has signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI). The ISCI is a pioneer in the field of cell-based regenerative medicine. Combining a world-class medical facility with a state-of-the-art laboratory, the ISCI provides investigational treatments to patients as part of clinical studies, while providing long-term follow up to advance these promising therapies. The acquisition of the ISCI provides the Company with an entry into stem cell research and treatment. With the advent of regenerative medicine, clinics such as the ISCI have taken the years of scientific research and started to apply them to treatment of patients. YaFarm Technologies President Brian Hermenze stated, "Since the 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B. Gurdon and Shinya Yamanaka for their work in stem cell research, we are very excited about the synergies this acquisition will bring to the Company. The ISCI has been providing point-of-care therapies to patients for over a year and operates at an internationally recognized medical facility accredited by both the Joint Commission and … Continue reading →

PITTSTON, ME--(Marketwire - Feb 5, 2013) - YaFarm Technologies, Inc. ( PINKSHEETS : YFRM ) (YaFarm, or the Company) is pleased to announce that it has signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI). The ISCI is a pioneer in the field of cell-based regenerative medicine. Combining a world-class medical facility with a state-of-the-art laboratory, the ISCI provides investigational treatments to patients as part of clinical studies, while providing long-term follow up to advance these promising therapies. The acquisition of the ISCI provides the Company with an entre into stem cell research and treatment. With the advent of regenerative medicine, clinics such as the ISCI have taken the years of scientific research and started to apply them to treatment of patients. YaFarm Technologies CEO Brian Hermenze stated, "Since the 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B. Gurdon and Shinya Yamanaka for their work in stem cell research, we are very excited about the synergies this acquisition will bring to the Company. The ISCI has been providing point-of-care therapies to patients for over a year and operates at an internationally recognized medical facility accredited by both the Joint Commission and … Continue reading →